EVOKE PHARMA, INC. Cash and Cash Equivalents
EVOKE PHARMA, INC. had Cash and Cash Equivalents of $11.58 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-11-13
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $11.58M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $12.06M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $12.62M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $13.60M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $11.58M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $12.06M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $12.62M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $13.60M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $11.34M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $9.18M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $9.70M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.74M 10-K · filed 2025-03-13 |
| 2023-09-30 | $5.96M 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $7.01M 10-K/A · filed 2024-05-14 |
| 2023-03-31 | $8.21M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $9.84M 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $12.35M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $13.45M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $7.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $9.14M 10-K · filed 2023-03-21 |
| 2021-09-30 | $11.14M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $16.72M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $18.19M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $8.07M 10-K · filed 2022-03-08 |
| 2020-09-30 | $6.28M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $7.99M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $4.13M 10-Q · filed 2021-05-12 |
| 2019-12-31 | $5.66M 10-K · filed 2022-03-08 |
| 2019-09-30 | $6.50M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $7.44M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $4.03M 10-Q · filed 2020-05-12 |
| 2018-12-31 | $5.32M 10-K · filed 2021-03-11 |
| 2018-09-30 | $6.57M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $6.53M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $5.41M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $7.68M 10-K · filed 2020-03-12 |
| 2017-09-30 | $10.41M 10-Q · filed 2018-11-13 |
| 2017-06-30 | $12.56M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $14.65M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $9.01M 10-K · filed 2019-03-06 |
| 2016-09-30 | $10.38M 10-Q · filed 2017-11-14 |
| 2016-06-30 | $4.13M 10-Q · filed 2017-08-14 |
| 2016-03-31 | $6.10M 10-Q · filed 2017-05-15 |
| 2015-12-31 | $8.69M 10-K · filed 2018-03-07 |
| 2015-09-30 | $10.74M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $9.88M 10-Q · filed 2016-08-15 |
| 2015-03-31 | $11.69M 10-Q · filed 2016-05-11 |
| 2014-12-31 | $14.16M 10-K · filed 2017-03-15 |
| 2014-09-30 | $12.18M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $16.05M 10-Q · filed 2015-08-13 |
| 2014-03-31 | $21.84M 10-Q · filed 2015-05-14 |
| 2013-12-31 | $24.20M 10-K · filed 2016-03-10 |
| 2013-09-30 | $23.74M 10-Q · filed 2014-11-13 |
| 2013-06-30 | $1.05M 10-Q · filed 2014-08-13 |
| 2013-03-31 | $1.67M 10-Q · filed 2014-05-13 |
| 2012-12-31 | $116.01K 10-K · filed 2015-03-04 |
| 2012-09-30 | $768.77K 10-Q · filed 2013-11-13 |
| 2011-12-31 | $865.88K 10-K · filed 2014-03-25 |
| 2010-12-31 | $4.04M 10-K · filed 2014-03-25 |